Literature DB >> 8758045

Predictors of outcome in Cryptococcus neoformans var. gattii meningitis.

R A Seaton1, S Naraqi, J P Wembri, D A Warrell.   

Abstract

In Papua New Guinea, Cryptococcus neoformans var. gattii meningitis has a high fatality rate even in immunocompetent patients. Our retrospective study attempted to identify marker of poor prognosis. Of 88 immunocompetent patients, 30 (34.1%) died, usually soon after admission, and mortality was higher in men (p = 0.025) and older patients (p = 0.039). Death was associated with altered consciousness (p < 0.001), a history of convulsions prior to treatment (p = 0.002) and a maximum systolic blood pressure of > 150 mmHg (p = 0.017). These data suggest that death results from raised intracranial pressure and subsequent tentorial herniation. However, CSF opening pressure measured on admission was raised in 29/36 (81%) patients and did not predict outcome. In survivors, relapse was uncommon and was not predicted by discharge serum cryptococcal antigen titres, which were frequently raised on completion of therapy in asymptomatic patients. Mortality may be reduced if efforts are made to lower intracranial pressure in those patients who present with markers of poor prognosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8758045     DOI: 10.1093/qjmed/89.6.423

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  13 in total

Review 1.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Quantitation of cellular components in Cryptococcus neoformans for system biology analysis.

Authors:  Arpita Singh; Asfia Qureshi; Maurizio Del Poeta
Journal:  Methods Mol Biol       Date:  2011

3.  A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.

Authors:  Tran Th Chau; Nguyen H Mai; Nguyen H Phu; Ho D Nghia; Ly V Chuong; Dinh X Sinh; Van A Duong; Pham T Diep; James I Campbell; Stephen Baker; Tran T Hien; David G Lalloo; Jeremy J Farrar; Jeremy N Day
Journal:  BMC Infect Dis       Date:  2010-07-09       Impact factor: 3.090

4.  Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007.

Authors:  Eleni Galanis; Laura Macdougall; Sarah Kidd; Mohammad Morshed
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

5.  Allergen1 regulates polysaccharide structure in Cryptococcus neoformans.

Authors:  Neena Jain; Radames J B Cordero; Arturo Casadevall; Bettina C Fries
Journal:  Mol Microbiol       Date:  2013-04-09       Impact factor: 3.501

6.  Isolation of Cryptococcus gattii from Oregon soil and tree bark, 2010-2011.

Authors:  Emilio DeBess; Shawn R Lockhart; Naureen Iqbal; Paul R Cieslak
Journal:  BMC Microbiol       Date:  2014-12-21       Impact factor: 3.605

7.  Is Cryptococcus gattii a Primary Pathogen?

Authors:  Kyung J Kwon-Chung; Tomomi Saijo
Journal:  J Fungi (Basel)       Date:  2015-07-29

8.  Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest.

Authors:  Rachel M Smith; Adamma Mba-Jonas; Mathieu Tourdjman; Trisha Schimek; Emilio DeBess; Nicola Marsden-Haug; Julie R Harris
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

9.  Predictors and long-term outcome of seizures in human immuno-deficiency virus (HIV)-negative cryptococcal meningitis.

Authors:  Chih-Wei Hung; Wen-Neng Chang; Chia-Te Kung; Nai-Wen Tsai; Hung-Chen Wang; Wei-Che Lin; Chi-Ren Huang; Chih-Cheng Huang; Wan-Chen Tsai; Hsueh-Wen Chang; Yu-Jih Su; Yu-Jun Lin; Ben-Chung Cheng; Ya-Ting Chang; Chih-Min Su; Cheng-Hsien Lu
Journal:  BMC Neurol       Date:  2014-10-13       Impact factor: 2.474

10.  Disseminated Cryptococcosis in a Non-HIV Patient in Singapore.

Authors:  Jonathan See; Kok Choon Raymond Fong; Humaira Shafi
Journal:  Case Rep Infect Dis       Date:  2019-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.